Cholesterol and Lipid Metabolism STUDIES

Highlights ENDUR-ACIN® significantly improves blood lipids in patients with hyperlipidemia Effective dosage is 1,500 to 2,000 mg/day Significant improvements in blood lipids and transfer proteins reported Low 5% dropout rate...

Highlights ENDUR-ACIN® therapy improves lipid profiles in men with dyslipidemia comparable to lovastatin therapy. Summary This randomized, double-blind, controlled trial, completed by University of Minnesota researcher Joseph Keenan, M.D., in...

Highlights ENDUR-ACIN® improves serum lipid profiles in patients with dyslididemia and hypertension. ENDUR-ACIN® helps normalize cerebrovascular tone and reactivity. ENDUR-ACIN® exerts a mild hypertensive effect. Summary This open-label trial was...

Highlights Comparison of ENDUR-ACIN® and prescription controlled-release niacin (Nicobid). Both products exhibit controlled release, but ENDUR-ACIN® had a more rapid dissolution rate. Compared to Nicobid, ENDUR-ACIN® has a two-fold increase...

Highlights ENDUR-ACIN® improves blood lipids in men with and without CHD Effective dosage is 1,500 to 2,000 mg/day for 4 months Increases in HDL cholesterol and apo-AI levels higher in...